Abstract

Background and Objectives: Calcifying fibrous tumor (CFT) in the stomach is extremely rare and is easily misdiagnosed as a gastrointestinal stromal tumor (GIST). This study aims to determine the best method to differentiate between gastric CFT and GIST after a systemic review and meta-analysis. Materials and Methods: A systematic search of articles using electronic databases (MEDLINE, EMBASE, and LILACS) was conducted and resulted in 162 articles with 272 CFT cases published from January 1988 to September 2019. Results: Of these cases, 272 patients, 60 patients with gastric CFT (32 men and 28 women, mean age 49.2 years) were analyzed. The mean tumor size was 2.4 cm in patients with gastric CFT. Both endoscopic ultrasound (EUS) and computed tomography (CT) findings revealed well-defined (100% vs. 77.8%), heterogeneous (100% vs. 77.8%), iso-hypoechoic (71.4% vs. 33.3%), and calcified (85.7% vs. 77.8%) lesions, respectively. The majority of patients (53.3%) were symptomatic, with the most common symptom being abdominal discomfort (55.6%). None of the patients with gastric CFT showed recurrence after treatment, and most patients received nonendoscopic treatment (56%, n = 28/50). Both age and tumor size were statistically significant in patients with gastric CFT than GIST (49.2 vs. 65.0 years and 2.4 vs. 6.0 cm; both p < 0.001). The ratio of children among patients with CFT (5%) and GIST (0.05%) was also significantly different (p = 0.037). The calcification rates of gastric CFT had significantly higher calcification rates than GIST on images of EUS and CT (85.7% vs. 3.6% and 77.8% vs. 3.6%; both p < 0.001). Conclusions: Compared with patients with GIST, patients with gastric CFT were younger, had smaller tumor size, and were symptomatic. Furthermore, gastric CFT was well-defined, heterogeneous in the third layer, and had high calcification rates on the images.

Highlights

  • A submucosal tumor (SMT) is a term used by endoscopists to depict any protuberance with intact mucosa

  • One hundred and thirty-one articles were excluded for the following reasons: a study that included cases with calcifying fibrous tumor (CFT) but not in the stomach (n = 113), cases with gastric CFT but not the primary lesion (n = 2), articles not obtainable (n = 2), and articles not published in English (n = 15)

  • (53.3%, n = 32/60) were symptomatic with a leading symptom of abdominal discomfort; (iv) most patients (56%, n = 28/50) received nonendoscopic treatment; (v) all patients (n = 60) did not recur after treatment; and (vi) CFT is statically different from gastrointestinal stromal tumor (GIST) in age, size, and imaging calcification rate

Read more

Summary

Introduction

A submucosal tumor (SMT) is a term used by endoscopists to depict any protuberance with intact mucosa. Calcifying fibrous tumor (CFT) in the stomach is extremely rare and is misdiagnosed as a gastrointestinal stromal tumor (GIST). The mean tumor size was 2.4 cm in patients with gastric CFT. Both endoscopic ultrasound (EUS) and computed tomography (CT) findings revealed well-defined (100% vs 77.8%), heterogeneous (100% vs 77.8%), iso-hypoechoic (71.4% vs 33.3%), and alcified (85.7% vs 77.8%) lesions, respectively. None of the patients with gastric CFT showed recurrence after treatment, and most patients received nonendoscopic treatment (56%, n = 28/50) Both age and tumor size were statistically significant in patients with gastric CFT than GIST (49.2 vs 65.0 years and 2.4 vs 6.0 cm; both p < 0.001)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call